122 related articles for article (PubMed ID: 22229480)
1. C-reactive protein and nitric oxide level in patients with white coat hypertension.
Guven A; Tolun F; Caliskan M; Ciftci O; Muderrisoglu H
Blood Press; 2012 Oct; 21(5):281-5. PubMed ID: 22229480
[TBL] [Abstract][Full Text] [Related]
2. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension.
Curgunlu A; Uzun H; Bavunoğlu I; Karter Y; Genç H; Vehid S
J Hum Hypertens; 2005 Aug; 19(8):629-33. PubMed ID: 15829997
[TBL] [Abstract][Full Text] [Related]
3. Endothelium and angiogenesis in white coat hypertension.
Karter Y; Aydin S; Curgunlu A; Uzun H; Ertürk N; Vehid S; Kutlu A; Simsek G; Yücel R; Arat A; Ozturk E; Erdine S
J Hum Hypertens; 2004 Nov; 18(11):809-14. PubMed ID: 15215878
[TBL] [Abstract][Full Text] [Related]
4. Endothelial damage in white coat hypertension: role of lectin-like oxidized low-density lipoprotein-1.
Yavuzer S; Yavuzer H; Cengiz M; Erman H; Altıparmak MR; Korkmazer B; Balci H; Simsek G; Yaldıran AL; Karter Y; Uzun H
J Hum Hypertens; 2015 Feb; 29(2):92-8. PubMed ID: 25007999
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin and Pentraxin-3: Current biomarkers in inflammation in white coat hypertension.
Yavuzer H; Cengiz M; Yavuzer S; Rıza Altıparmak M; Korkmazer B; Balci H; Yaldıran AL; Uzun H
J Hum Hypertens; 2016 Jul; 30(7):424-9. PubMed ID: 26040439
[TBL] [Abstract][Full Text] [Related]
6. Long-term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements.
Mancia G; Bombelli M; Brambilla G; Facchetti R; Sega R; Toso E; Grassi G
Hypertension; 2013 Jul; 62(1):168-74. PubMed ID: 23716584
[TBL] [Abstract][Full Text] [Related]
7. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index.
Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J
Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of white coat hypertension in Chinese Han patients with type 2 diabetes mellitus.
Zhou J; Liu C; Shan P; Zhou Y; Xu E; Ji Y
Clin Exp Hypertens; 2014; 36(5):321-5. PubMed ID: 24047449
[TBL] [Abstract][Full Text] [Related]
9. Heart rate turbulence in masked hypertension and white-coat hypertension.
Song CL; Zhang X; Liu YK; Yue WW; Wu H
Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1457-60. PubMed ID: 25967722
[TBL] [Abstract][Full Text] [Related]
10. The impact of protein oxidation on sustained and white coat hypertension.
Yıldırım E; İpek E; Bavunoğlu I; Yıldırım N; Cengiz M; Yavuzer S; Yavuzer H; Erman H; Uzun H
Anatol J Cardiol; 2017 Mar; 17(3):210-216. PubMed ID: 27684518
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia: an additional risk factor in white coat hypertension.
Curgunlu A; Karter Y; Uzun H; Aydin S; Ertürk N; Vehid S; Simsek G; Kutlu A; Oztürk E; Erdine S
Int Heart J; 2005 Mar; 46(2):245-54. PubMed ID: 15876808
[TBL] [Abstract][Full Text] [Related]
12. Effect of masked, white-coat, and sustained hypertension on coronary flow reserve and peripheral endothelial functions.
Caliskan M; Ciftci O; Gullu H; Caliskan Z; Güven A; Erdogan D; Muderrisoglu H
Clin Exp Hypertens; 2013; 35(3):183-91. PubMed ID: 22891712
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte DNA damage and total antioxidant status in patients with white-coat hypertension and sustained hypertension.
Yildiz A; Gür M; Yilmaz R; Demirbağ R; Celik H; Aslan M; Koçyiğit A
Turk Kardiyol Dern Ars; 2008 Jun; 36(4):231-8. PubMed ID: 18765966
[TBL] [Abstract][Full Text] [Related]
14. Endothelial function in sustained and white coat hypertension.
Pierdomenico SD; Cipollone F; Lapenna D; Bucci A; Cuccurullo F; Mezzetti A
Am J Hypertens; 2002 Nov; 15(11):946-52. PubMed ID: 12441213
[TBL] [Abstract][Full Text] [Related]
15. Office blood pressure is a predictor of aortic elastic properties and urinary protein excretion in subjects with white coat hypertension.
Aznaouridis K; Vlachopoulos C; Masoura K; Pietri P; Vyssoulis G; Ioakeimidis N; Stefanadis C; Tousoulis D
Int J Cardiol; 2016 Jan; 203():98-103. PubMed ID: 26498870
[TBL] [Abstract][Full Text] [Related]
16. The Cardiovascular Risk of White-Coat Hypertension.
Franklin SS; Thijs L; Asayama K; Li Y; Hansen TW; Boggia J; Jacobs L; Zhang Z; Kikuya M; Björklund-Bodegård K; Ohkubo T; Yang WY; Jeppesen J; Dolan E; Kuznetsova T; Stolarz-Skrzypek K; Tikhonoff V; Malyutina S; Casiglia E; Nikitin Y; Lind L; Sandoya E; Kawecka-Jaszcz K; Filipovský J; Imai Y; Wang JG; O'Brien E; Staessen JA;
J Am Coll Cardiol; 2016 Nov; 68(19):2033-2043. PubMed ID: 27810041
[TBL] [Abstract][Full Text] [Related]
17. Relationships of different blood pressure categories to indices of inflammation and platelet activity in sustained hypertensive patients with uncontrolled office blood pressure.
Erdogan D; Icli A; Aksoy F; Akcay S; Ozaydin M; Ersoy I; Varol E; Dogan A
Chronobiol Int; 2013 Oct; 30(8):973-80. PubMed ID: 23834704
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein and B-type natriuretic peptides in never-treated white coat hypertensives.
Conen D; Dieterle T; Utech K; Rimner M; Martina B
Hypertens Res; 2006 Jun; 29(6):411-5. PubMed ID: 16940703
[TBL] [Abstract][Full Text] [Related]
19. White coat hypertension and obstructive sleep apnea.
Li L; Guo LZ; Li J; Wang Y; Liu X; Lv YH; Ma CS
Sleep Breath; 2015 Dec; 19(4):1199-203. PubMed ID: 25680548
[TBL] [Abstract][Full Text] [Related]
20. The relationship between soluble CD40 ligand level and atherosclerosis in white-coat hypertension.
Huang YQ; Jie LI; Chen JY; Tang ST; Huang C; Feng YQ
J Hum Hypertens; 2017 Dec; 32(1):40-45. PubMed ID: 29162926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
